Latest 10-K annual reports

Perpetua Resources progresses its Stibnite Gold Project with key federal permits, securing substantial equity and a $2.7 billion U.S. EXIM loan notification, despite ongoing legal challenges and a net loss.

Cocrystal Pharma's annual report highlights significant financial challenges, including a going concern doubt and a failed Phase 2a influenza trial, despite progress in other antiviral programs.

Palvella Therapeutics announced positive Phase 3 clinical trial results for QTORIN rapamycin in microcystic lymphatic malformations and secured $215.8 million in a public offering, despite ongoing operating losses.

1847 Holdings LLC reported a significant turnaround in net income and revenue for 2025, driven by its construction segment, despite auditors issuing a going concern opinion due to substantial liabilities and near-term debt maturities.

Dominari Holdings Inc. announced a significant revenue surge in 2025 driven by its financial services expansion, despite reporting a larger net loss and identifying material weaknesses in internal controls.

AquaBounty Technologies, Inc. has significantly restructured its operations by divesting key assets and pausing its Ohio Farm Project, leading to substantial impairment charges and raising doubts about its ability to continue as a going concern.

AirJoule Technologies Corporation reported a net loss of $9.0 million for 2025, driven by significant impairment charges in its AirJoule JV, despite advancing its water harvesting technology and securing new capital.

LM Funding America, Inc. reported a significantly increased net loss for 2025, driven by decreased Bitcoin mining revenue and impairment losses, while facing a Nasdaq delisting notice.

Galectin Therapeutics reports 2025 annual results, highlighting mixed NAVIGATE trial outcomes for belapectin in MASH cirrhosis and ongoing financing needs.

Latch, Inc., now operating as DOOR, reported a net loss of $53.7 million for 2025, alongside revenue growth and ongoing efforts to remediate material weaknesses in internal controls.

YHN Acquisition I Limited, a SPAC, has extended its business combination deadline to June 19, 2026, and reported a net income of $1.33 million for 2025, while facing going concern doubts.

BT Brands reported improved net loss and EBITDA in fiscal 2025 while announcing a major strategic shift to unmanned aerial vehicles and a spin-off of its restaurant operations.

Firefly Neuroscience, Inc. reported a 957% revenue increase to $1.142 million in 2025, driven by the Evoke acquisition, but faces substantial doubt about its ability to continue as a going concern due to recurring losses and negative cash flows.

ZW Data Action Technologies Inc. reported a significant revenue decline in 2025 to $4.61 million from $15.44 million in 2024, alongside a reduced net loss, as it strategically shifts focus to higher-margin digital advertising and AI/blockchain services outside mainland China.

Xtant Medical Holdings, Inc. achieved net income in 2025 driven by license revenue and orthobiologics sales, despite divesting Coflex/CoFix assets and international hardware business, which will impact 2026 revenues.

NexPoint Diversified Real Estate Trust reported a substantial net loss of $127 million in 2025, driven by mark-to-market losses on investments, while actively pursuing strategic asset reallocation and capital raises.

Charlotte's Web Holdings reports mixed 2025 results, showing slight revenue growth and reduced operating losses, driven by product diversification and cost-cutting, while facing significant regulatory uncertainty and a substantial capital raise from BAT.

Thunder Mountain Gold, an exploration-stage company, reported a net loss of $2.83 million for fiscal year 2025, while advancing its South Mountain Project with increased mineral resources and strategic partnerships.

VerifyMe, Inc. reports a 32% revenue drop and increased net loss for 2025, driven by a key carrier partnership loss and significant impairment charges, while pursuing a highly dilutive merger with Open World Ltd.

BlockchAIn Digital Infrastructure, Inc. completed a business combination, shifted its focus to AI/HPC, and reported a net loss of $0.8 million for 2025, down from a $5.7 million net income in 2024.

Meridian Holdings grew FY2025 revenue 21% to $182.9M but booked $91.8M of non‑cash impairments, swinging to a $92.0M net loss and ending the year with a $24.1M working capital deficit.

First Foundation Inc. filed an amended annual report for 2025, detailing corporate governance, executive compensation, and revealing a significant net loss and negative return on equity.

Allbirds, Inc. reported significant net losses and revenue decline for fiscal year 2025, raising substantial doubt about its ability to continue as a going concern, and announced a definitive agreement to sell substantially all assets.

Solana Company, formerly Helius Medical Technologies, Inc., has strategically shifted its focus to a digital asset treasury centered on Solana tokens, reporting a net loss of $40.9 million for 2025 amidst significant market volatility.

Laird Superfood, Inc. reports increased net sales for FY2025, driven by wholesale growth, alongside a strategic acquisition of Navitas Organics and a $50 million investment from Nexus Capital Management LP.

Haymaker Acquisition Corp. 4 reported a net loss for 2025 while progressing towards its business combination with Suncrete, extending its deadline to July 2026.

TherapeuticsMD reports reduced net loss and increased license revenue in 2025, but faces substantial doubt about its going concern status due to ongoing legal disputes and liquidity challenges.

DeFi Development Corp. shifted its primary strategy in 2025 to focus on the Solana blockchain ecosystem, reporting a substantial net loss of $73.8 million for the year.

BGSF, Inc. reported substantial net losses from continuing operations for fiscal year 2025, alongside a strategic divestiture of its Professional segment and a special cash dividend.

Peraso Inc. reported a significantly reduced net loss of $4.8 million in 2025, driven by a shift to mmWave products and ongoing strategic review discussions, despite a decline in overall revenue and persistent going concern doubt.